Your browser doesn't support javascript.
loading
Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials.
Izcovich, Ariel; Siemieniuk, Reed Alexander; Bartoszko, Jessica Julia; Ge, Long; Zeraatkar, Dena; Kum, Elena; Qasim, Anila; Khamis, Assem M; Rochwerg, Bram; Agoritsas, Thomas; Chu, Derek K; McLeod, Shelley L; Mustafa, Reem A; Vandvik, Per; Brignardello-Petersen, Romina.
Afiliación
  • Izcovich A; Department of Internal Medicine, Hospital Alemán de Buenos Aires, Buenos Aires, Argentina ariel.izcovich@gmail.com.
  • Siemieniuk RA; Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.
  • Bartoszko JJ; Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.
  • Ge L; Evidence Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.
  • Zeraatkar D; Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.
  • Kum E; Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.
  • Qasim A; Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.
  • Khamis AM; Hull York Medical School, University of Hull, York, UK.
  • Rochwerg B; Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.
  • Agoritsas T; Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.
  • Chu DK; Division of General Internal Medicine & Division of Epidemiology, University Hospitals of Geneva, Geneva, Switzerland.
  • McLeod SL; Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.
  • Mustafa RA; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Vandvik P; Schwartz/Reisman Emergency Medicine Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Brignardello-Petersen R; Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
BMJ Open ; 12(3): e048502, 2022 03 02.
Article en En | MEDLINE | ID: mdl-35236729
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adenosina Monofosfato / Ritonavir / Alanina / Lopinavir / Tratamiento Farmacológico de COVID-19 / Hidroxicloroquina Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article País de afiliación: Argentina
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adenosina Monofosfato / Ritonavir / Alanina / Lopinavir / Tratamiento Farmacológico de COVID-19 / Hidroxicloroquina Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article País de afiliación: Argentina